Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small spot of blood when you remove your Wegovy pen is common and almost always harmless. Most people see a tiny bead of blood at the site, which stops within a minute or two. It does not mean the medicine has leaked, and it doesn't change how well the dose works. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins. This page explains why bleeding happens, how to tell normal from unusual, and when to seek advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The semaglutide in Wegovy is injected into the fatty layer just beneath the skin, using a fine needle. Fatty tissue is crisscrossed with tiny capillaries, and the needle occasionally nicks one. That produces the small droplet most people notice when they lift the pen away. It is one of the most common injection-site reactions described in clinical reporting, and the NHS medicines information on semaglutide lists injection-site reactions, including minor bleeding, among the expected local effects.
The needle diameter used in the Wegovy pen is deliberately narrow to minimise discomfort and tissue disruption. Even so, skin thickness, capillary density and injection angle all vary slightly person to person and week to week, which is why bleeding might happen one week and not the next. Cold skin can also make capillaries sit closer to the surface; letting the pen reach room temperature for a few minutes before injecting can help.
Worth knowing: the medicine is already fully deposited by the time you see the blood. A surface capillary bleed has no effect on how much semaglutide your body absorbs, and if you notice a burning sensation at the injection site with Wegovy, that is a separate local reaction also explained in our guidance. Pressing gently with a clean cotton ball or gauze for 30 to 60 seconds is usually enough.
A question our prescribers hear most weeks is whether the small bruise that sometimes follows a bleed means something went wrong. The short answer: not usually. When a tiny capillary is nicked, blood may spread a little under the skin rather than appearing at the surface, producing a bruise over the next day or two. This is a normal local response, not a sign of infection or a clotting problem.
There is more detail on how to distinguish a routine injection-site bruise from something worth investigating in our guide to bruising at the injection site with Wegovy. In short, a bruise that is small, not warm to touch, and fades over five to seven days needs nothing more than site rotation the following week.
If you are taking blood-thinning medicines, aspirin, or certain anti-inflammatory drugs, surface bleeding and bruising can be more pronounced, this is an interaction worth flagging to your prescriber before you start, not something to manage alone. Semaglutide itself does not interfere with clotting, but pre-existing medication affects your baseline.
Technique plays a part too. Injecting through an area that is already bruised increases the chance of bleeding; rotating properly between approved injection sites on your abdomen, thighs and upper arms means no single patch of skin faces repeated trauma.
Small changes to how you handle the pen make a reliable difference. First, avoid injecting into skin that is red, tender or already bruised from a previous dose. Pinching the skin gently before pressing the pen can lift the fatty layer slightly away from underlying muscle, reducing the chance of a deeper nick. Hold the pen firmly against the skin at a 90-degree angle and keep it still for the full hold count before withdrawing; releasing early is a common cause of both leakage and minor bleeding.
Alcohol swabs can dry and firm the skin if left to evaporate fully, apply the swab, let the area air-dry for about 15 seconds, then inject rather than injecting immediately after wiping. Medical-grade alcohol swabs designed for injection preparation are straightforward to include in your weekly routine. Do not rub the site after injection; gentle pressure only.
Using a fresh needle each time is equally important. A reused needle has a slightly blunted tip that drags through tissue rather than parting it cleanly, increasing both discomfort and the chance of a small bleed. If you have questions about how to store and handle your pen correctly, the full injection-site guidance page covers storage conditions alongside technique in detail.
For those who find the abdomen uncomfortable, the upper arm as an injection site can be a practical alternative, though it typically requires a second person or a specific self-injection technique to keep the skin taut.
Most surface bleeds need nothing beyond a minute of gentle pressure. Seek advice promptly if bleeding does not settle within five minutes with direct pressure, if you notice a rapidly expanding haematoma (a firm, swollen lump that grows under the skin rather than a flat bruise), or if the site becomes hot, swollen and increasingly painful over the days following the injection, which can signal infection.
Signs of an allergic reaction to the injection are distinct from local bleeding: these include hives, swelling of the face or throat, difficulty breathing or feeling faint. If any of those occur, stop the injection and seek emergency help immediately. They are rare but documented in prescribing information.
The MHRA's Yellow Card scheme allows anyone to report suspected side effects directly, including unexpected injection-site reactions. Your report contributes to the ongoing safety monitoring of medicines like Wegovy and is encouraged, particularly for anything that seems disproportionate to what you expected.
If you are newly starting treatment and want a clear picture of what the full injection process involves, the injection-sites diagram is a useful visual reference. And if you have broader questions about how Wegovy fits your situation, our free consultation connects you with a GPhC-registered prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.